Brief: Abbvie Reaches Agreement With The Pan-Canadian Pharmaceutical Alliance (Pcpa) For Elahere® In Platinum-Resistant Ovarian Cancer
Today 12:31
BRIEF-Abbvie Reaches Agreement With The Pan-Canadian Pharmaceutical Alliance (Pcpa) For Elahere® In Platinum-Resistant Ovarian Cancer Oct 21 (Reuters) - AbbVie Inc. ABBV.N:
ABBVIE REACHES AGREEMENT WITH THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA) FOR ELAHERE® IN PLATINUM-RESISTANT OVARIAN CANCER
ABBVIE: LOOKS FORWARD TO COLLABORATION WITH PROVINCIAL & TERRITORIAL GOVERNMENTS TO SUPPORT TIMELY & EQUITABLE PUBLIC REIMBURSEMENT OF ELAHERE
Source text: ID:nCNW9Z0xra
Further company coverage: ABBV.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbbVie
See all newsBrief: Abbvie Reaches Agreement With The Pan-Canadian Pharmaceutical Alliance (Pcpa) For Elahere® In Platinum-Resistant Ovarian Cancer
Eli Lilly hits record high as healthcare stocks rally
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Abbvie Says Risankizumab In Ulcerative Colitis Shows Clinical Remission Rates Of 54.0%-73.1% At Week 96